These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11056316)
1. Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT). Dunn BK; Ford LG Eur J Cancer; 2000 Sep; 36 Suppl 4():S49-50. PubMed ID: 11056316 [No Abstract] [Full Text] [Related]
2. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Vogel VG; Costantino JP; Wickerham DL; Cronin WM J Natl Cancer Inst; 2002 Oct; 94(19):1504. PubMed ID: 12359860 [No Abstract] [Full Text] [Related]
3. Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial. Wickerham DL Recent Results Cancer Res; 2003; 163():87-95; discussion 264-6. PubMed ID: 12903845 [TBL] [Abstract][Full Text] [Related]
4. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ. Vogel VG; Costantino JP; Wickerham DL; Cronin WM Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen--an update on current data and where it can now be used. Wickerham L Breast Cancer Res Treat; 2002 Oct; 75 Suppl 1():S7-12; discussion S33-5. PubMed ID: 12353826 [TBL] [Abstract][Full Text] [Related]
6. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women. Jahanzeb M Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537 [TBL] [Abstract][Full Text] [Related]
7. Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women. Cella D; Land SR; Chang CH; Day R; Costantino JP; Wolmark N; Ganz PA Breast Cancer Res Treat; 2008 Jun; 109(3):515-26. PubMed ID: 17851765 [TBL] [Abstract][Full Text] [Related]
8. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Powles TJ J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518 [No Abstract] [Full Text] [Related]
9. The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. Love RR Cancer Epidemiol Biomarkers Prev; 1993; 2(5):403-7. PubMed ID: 8220082 [No Abstract] [Full Text] [Related]
10. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Narod S J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863 [No Abstract] [Full Text] [Related]
11. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Vogel VG Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233 [TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial. Land SR; Cronin WM; Wickerham DL; Costantino JP; Christian NJ; Klein WM; Ganz PA Cancer Prev Res (Phila); 2011 Sep; 4(9):1393-400. PubMed ID: 21862698 [TBL] [Abstract][Full Text] [Related]
13. Prevention of hormone-related cancers: breast cancer. Dunn BK; Wickerham DL; Ford LG J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. King MC; Wieand S; Hale K; Lee M; Walsh T; Owens K; Tait J; Ford L; Dunn BK; Costantino J; Wickerham L; Wolmark N; Fisher B; JAMA; 2001 Nov; 286(18):2251-6. PubMed ID: 11710890 [TBL] [Abstract][Full Text] [Related]
15. Final results from the NSABP Breast Cancer Prevention Trial. Oncology (Williston Park); 2005 Dec; 19(14):1800. PubMed ID: 16506633 [No Abstract] [Full Text] [Related]
16. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators. Reis SE; Costantino JP; Wickerham DL; Tan-Chiu E; Wang J; Kavanah M J Natl Cancer Inst; 2001 Jan; 93(1):16-21. PubMed ID: 11136837 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen and breast cancer--from palliation to prevention. Rich SE Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194 [TBL] [Abstract][Full Text] [Related]
18. [Chemoprevention of breast cancer: a hope justified?]. Buser K; Delaloye JF Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095 [TBL] [Abstract][Full Text] [Related]
19. Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Cuzick J; Forbes JF; Howell A J Natl Cancer Inst; 2006 May; 98(9):643; author reply 643-4. PubMed ID: 16670391 [No Abstract] [Full Text] [Related]
20. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]